Prevention of catheter-related bloodstream infections in the neonatal intensive care setting

Expert Review of Anti-Infective Therapy

Volumn 4, Issue 5, 2006, Pages 861-873

  Gilad, Jacob ^a   Borer, Abraham ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Bloodstream infection; Catherer; Infection control; Intensive care; Neonate; Nosocomial

Indexed keywords

ALCOHOL; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; MICONAZOLE; MINOCYCLINE; NYSTATIN; POVIDONE IODINE; PROBIOTIC AGENT; PYRROLE DERIVATIVE; RIFAMPICIN; SULFADIAZINE SILVER; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTISEPSIS; CATHETER INFECTION; CATHETERIZATION; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; DISINFECTION; DRUG USE; EVIDENCE BASED MEDICINE; HEALTH PROGRAM; HOSPITAL INFECTION; HOST; HUMAN; HYGIENE; IMMUNOMODULATION; INCIDENCE; INFECTION CONTROL; INFECTION PREVENTION; META ANALYSIS; MICROFLORA; MORBIDITY; MORTALITY; NEWBORN; NEWBORN INTENSIVE CARE; RANDOMIZATION; REVIEW; RISK FACTOR; SEPSIS; SYSTEMATIC REVIEW;

BLOOD-BORNE PATHOGENS; CATHETERIZATION, CENTRAL VENOUS; CROSS INFECTION; EQUIPMENT CONTAMINATION; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; INTENSIVE CARE, NEONATAL; SEPSIS;

EID: 33845443410     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.4.5.861     Document Type: Review

References (103)

1. Marodi L. Neonatal innate immunity to infectious agents. Infect. Immun. 74, 1999-2006 (2006).
2. Brady MT. Health care-associated infections in the neonatal intensive care unit. Am. J. Infect. Control 33, 268-275 (2005).
3. Kaufman D, Fairchild KD. Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants. Clin. Microbiol. Rev. 17, 638-680 (2004).
4. Stoll BJ, Hansen N. Infections in VLBW infants: studies from the NICHD neonatal research network. Sem. Perinatol. 27, 293-301 (2003).
5. Denta A, Toltzisa P. Descriptive and molecular epidemiology of Gram-negative bacilli infections in the neonatal intensive care unit. Curr. Opin. Inject. Dis. 16, 279-283 (2003).
6. Graham PL III, Begg MD, Larson E, Della-Latta P, Allen A, Saiman L. Risk factors for late onset Gram-negative sepsis in low birth weight infants hospitalized in the neonatal intensive care unit. Pediatr. Infect. Dis. J. 25, 113-117 (2006).
7. Nagata E, Brito AJS, Matsuo T. Nosocomial infections in a neonatal intensive care unit: incidence and risk factors. Am. J. Infect. Control 30, 26-31 (2002).
8. Kawagoe JY, Segre CAM, Pereira CR, Cardoso MFS, Silva CV, Fukushima JT. Risk factors for nosocomial infections in critically ill newborns: a 5-year prospective cohort study. Am. J. Infect. Control 29, 109-114 (2001).
9. Sohn AH, Garrett DO, Sinkowitz-Cochran RL et al. Prevalence of nosocomial infections in neonatal intensive care unit patients: results from the first national point-prevalence survey. J. Pediatr. 139, 821-827 (2001).
10. Benjamin DK Jr, Miller W, Garges H et al. Bacteremia, central catheters, and neonates: when to pull the line? Pediatrics 107, 1272-1276 (2001).
11. Cartwright DW. Central venous lines in neonates: a study of 2186 catheters. Arch. Dis. Child Fetal Neonatal Ed. 89, 504-508 (2004).
12. Centers for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infections. MMWR 10, 1-36 (2002).
13. Vermont CL, Hartwig NG, Fller A et al. Persistence of clones of coagulase-negative staphylococci among premature neonates in neonatal intensive care units: two-center study of bacterial genotyping and patient risk factors. J. Clin. Microbiol. 36, 2485-2490 (1998).
14. Raimundo O, Heusslery H, Bruhn JB et al. Molecular epidemiology of coagulase-negative staphylococcal bacteraemia in a newborn intensive care unit. J. Hosp. Infect. 51, 33-42 (2002).
15. Krediet TG, Mascini EM, van Rooij E et al. Molecular epidemiology of coagulase-negative staphylococci causing sepsis in a neonatal intensive care unit over an 11-year period. J. Clin. Microbiol. 42, 992-995 (2004).
16. McNeely DF, Saint-Louis F, Noel GJ. Neonatal enterococcal bacteremia: an increasingly frequent event with potentially untreatable pathogens. Pediatr. Infect. Dis. J. 15, 800-805 (1996).
17. Singh N, Leger MM, Campbell J, Short B, Campos JM. Control of vancomycin-resistant enterococci in the neonatal intensive ca unit. Infect. Control Hosp. Epidemiol. 26, 646-649 (2005).
18. Singh N, Patel KM, Leger MM et al. Risk of resistant infections with Enterobacteriaceae in hospitalized neonates. Pediatr. Infect. Dis. J. 21, 1029-1033 (2002).
19. Calil R, Marba S, Nowakonski A et al. Reduction in colonization and nosocomial infection by multiresistant bacteria in a neonatal unit after institution of educational measures and restriction in the use of cephalosporins. Infect. Control Hosp. Epidemiol. 29, 133-138 (2001).
20. Waters V, Larson E, Wu F et al. Molecular epidemiology of Gram-negative bacilli from infected neonates and health care workers' hands in neonatal intensive care units. Clin. Infect. Dis. 38, 1682-1687 (2004).
21. Huang YC, Su LH, Wu TL, Lin TY. Genotyping analysis of colonizing candidal isolates from very-low-birthweight infants in a neonatal intensive care unit. J. Hosp. Infect. 58, 200-203 (2004).
22. Saiman L, Ludington E, Dawson J et al. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr. Infect. Dis. J. 20, 1119-1124 (2001).
23. Linder N, Levit O, Klinger G et al. Risk factors associated with candidaemia in the neonatal intensive care unit: a case-control study. J. Hosp. Infect. 57, 321-324 (2004).
24. Fairchild KD, Tomkoria S, Sharp EC, Mena FV. Neonatal Candida glabrata sepsis: clinical and laboratory features compared with other Candida species. Pediatr. J. Infect. Dis. 21, 39-43 (2002).
25. Chapman RL, Faix RG. Invasive neonatal candidiasis: an overview. Semin. Perinatol. 27, 352-356 (2003).
26. Ohlsson A, Lacy JB. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. Cochrane Database Syst. Rev. 1, CD000361 (2004).
27. Carr R, Modi N, Dore C. G-CSF and GM-CSF for treating or preventing neonatal infections. Cochrane Database Syst. Rev. 3, CD003066 (2003).
28. Edwards WH, Conner JM, Soll RF for the Vermont Oxford Network Neonatal Skin Care Study Group. The effect of prophylactic ointment therapy on nosocomial sepsis rates and skin integrity in infants with birth weights of 501 to 1000g. Pediatrics 113, 1195-1203 (2004).
29. Conner JM, Soll RF, Edwards WH. Topical ointment for preventing infection in preterm infants. Cochrane Database Syst. Rev. 4, CD001150 (2003).
30. Bin-Nun A, Bromker R, Wilschanski M et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. J. Pediatr. 147, 192-196 (2005).
31. Lin HC, Bai-Horng S, Chen AC et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 115, 1-4 (2005).
32. Chien LY, Macnab Y, Aziz K et al. Variations in central venous catheter-related infection risks among Canadian neonatal intensive care units. Pediatr. Infect. Dis. J. 21, 505-511 (2002).
33. Wardle SP, Kelsall AWR, Yoxall CW, Subhedar NV. Percutaneous femoral arterial and venous catheterisation during neonatal intensive care. Arch. Dis. Child Fetal Neonatal Ed. 85, 119-122 (2001).
34. Mermel L. Prevention of intravascular catheter-related infections. Ann. Intern. Med. 132, 391-402 (2000).
35. Raad II, Hohn DC, Gilbreath BJ et al. Prevention of central venous catheter related infections by using maximal sterile barrier precautions during insertion. Infect. Control Hosp. Epidemiol. 15, 231-238 (1994).
36. Kilbride HW, Powers R, Wirtschafter D et al. Evaluation and development of potentially better practices to prevent neonatal nosocomial bacteremia. Pediatrics 111, 504-518 (2003).
37. Cowen J, Ellis SH, McAinsh J. Absorption of chlorhexidine from intact skin of newborn infants. Arch. Dis. Child 54, 379-383 (1979).
38. Garland JS, Buck RK, Maloney P. Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trial. Pediatr. Infect. Dis. J. 14, 510-516 (1995).
39. Garland JS, Henrickson K, Maki DG. The 2002 Hospital Infection Control Practices Advisory Committee Centers for Disease Control and Prevention: guideline for prevention of intravascular device-related infection. Pediatrics 110, 1009-1013 (2002).
40. Linder N, Davidovich N, Reichman B et al. Topical iodine-containing antiseptics and neonatal hypothyroidism in preterm infants. J. Pediatr. 131, 434-430 (1997).
41. Brown RS, Bloomfield S, Bednarek FJ, Mitchell ML, Braverman LE. Routine skin cleansing with povidone-iodine is not a common cause of transient hypothyroidism in North America: a prospective controlled study. Thyroid 7, 395-400 (1997).
42. Linder N, Prince S, Barzilai A et al. Disinfection with 10% povidone-iodine versus 0.5% chlorhexidine gluconate in 70% isopropanol in the neonatal intensive care unit. Acta Pediatr. 93, 205-210 (1994).
43. Hall NJ, Hartley J, Ade-Ajayi N et al. Bacterial contamination of central venous catheters during insertion: a double blind randomised controlled trial. Pediatr. Surg. Int. 21, 507-511 (2005).
44. Clark R, Powers R, White R, Bloom B, Sanchez P, Benjamin DK Jr. Prevention and treatment of nosocomial sepsis in NICU. J. Perinatol. 24, 446-453 (2004).
45. Mahieu LM, De Dooy JJ, De Muynck AO et al. Microbiology and risk factors for catheter exist-site and catheter hub colonization in neonatal intensive care unit patients. Infect. Control Hosp. Epidemiol. 22, 357-362 (2001).
46. Garland JS, Alex CP. Mueller CD et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 107, 1431-1436 (2001).
47. Oishi T, Iwata S, Nonoyama M, Tsuji A, Sunakawa K. Double-blind comparative study on the care of the neonatal umbilical cord using 80% ethanol with or without chlorhexidine. J. Hosp. Infect. 58, 34-37 (2004).
48. Borer A, Buchnik L, Golan A, Hyam E, Gilad J. Safety and efficacy of 2% chlorhexidine tincture for prevention of catheter-related bloodstream infection in the neonatal intensive-care unit. The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington DC, USA, 16-19 December 2005.
49. Adams-Chapman I, Stoll BJ. Prevention of nosocomial infections in the neonatal intensive care unit. Curr. Opin. Pediatr. 14, 157-164 (2002).
50. Mahieu LM, De Dooy JJ, Lenaerts AE, Ieven MM, De Muynck AO. Catheter manipulations and the risk of catheter-associated bloodstream infection in neonatal intensive care unit patients. J. Hosp. Infect. 48, 20-26 (2001).
51. Chowdhary SK, Parashar K, Buick RG, Gornall P, Corkery JJ. Central venous access through the peripheral route in surgical neonates: an audit of 125 consecutive lines from a regional neonatal centre. Pediatr. Surg. Int. 17, 433-435 (2001).
52. Kabra NS, Kumar M, Shah SS. Multiple versus single lumen umbilical venous catheters for newborn infants. Cochrane Database Syst. Rev. 3, CD004498 (2005).
53. Aly H, Herson V, Duncan A. Is bloodstream infection preventable among premature infants? A tale of two cities. Pediatrics 115, 1513-1518 (2005).
54. Inglis GDT, Davies MW. Prophylactic antibiotics to reduce morbidity and mortality in neonates with umbilical venous catheters. Cochrane Database Syst. Rev. 4, CD005251 (2005).
55. Austin NC, Darlow B. Prophylactic oral antifungal agents to prevent systemic candida infection in preterm infants. Cochrane Database Syst. Rev. 4, CD003478 (2003).
56. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N. Engl. J. Med. 345, 1660-1666 (2001).
57. Bertini G, Perugi S, Dani C, Filippi L, Pratesi S, Rubaltelli FF. Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weights infants. J. Pediatr. 147, 162-165 (2005).
58. Healy MC, Baker CJ, Zaccaria E, Campbell JR. Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit. J. Pediatr. 147, 166-171 (2005).
59. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Grossman LB. Twice weekly fluconazole prophylaxis for prevention of invasive candida infection in high-risk infants of <1000 grams birth weight. J. Pediatr. 147, 172-179 (2005).
60. Manzoni P, Arisio R, Mostert M et al. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study. Pediatrics 117, 22-32 (2006).
61. Fanaroff AA. Fluconazole for the prevention of fungal infections: get ready, get set, caution. Pediatrics 117, 214-215 (2006).
62. Pai MP, Pendland SL, Danziger LH. Antimicrobial-coated/bonded and impregnated intravascular catheters. Ann. Pharmacother. 35, 1255-1263 (2000).
63. Garland JS, Alex CP, Henrickson KJ, McAuliffe TL, Maki DG. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial. Pediatrics 116, 198-205 (2005).
64. Goldman DA. Epidemiology and prevention of pediatric viral respiratory infections in health care institutions. Emerg. Infect. Dis. 7, 249-253 (2001).
65. Jones BL, Gorman LJ, Simpson J et al. An outbreak of Serratia marcescens in two neonatal intensive care units. J. Hosp. Infect. 46, 314-319 (2000).
66. Van den Berg RW, Claahsen HL, Niessen M, Muytjens HL, Liem K, Voss A. Enterobacter cloacae outbreak in the NICU related to disinfected thermometers. J. Hosp. Infect. 45, 29-34 (2000).
67. Boszczowski I, Nicoletti C, Puccini DM et al. Outbreak of extended spectrum β-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit related to onychomycosis in a health care worker. Pediatr. Infect. Dis. J. 24, 648-650 (2005).
68. Horbar JD, Rogowski J, Plisek PE et al. Collaborative quality improvement for neonatal intensive care. Pediatrics 107, 14-22 (2001).
69. Tucker J, UK Neonatal Staffing Study Group. Patient volume, staffing, and workload in relation to risk-adjusted outcomes in a random stratified sample of UK neonatal intensive care units: a prospective evaluation. Lancet 359, 99-107 (2002).
70. Spence K, Tarnow-Mordi W, Duncan G et al. Measuring nursing workload in neonatal intensive care. J. Nurs. Manag. 14, 227-234 (2006).
71. Robert J, Fridkin SK, Blumberg HM et al. The influence of the composition of the nursing staff on primary bloodstream infection rates in a surgical intensive care unit. Infect. Control Hosp. Epidemiol. 21, 7-12 (2000).
72. Centers for Disease Control and Prevention. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA hand hygiene task force. MMWR 16, 1-45 (2002).
73. McNeil SA, Foster CL, Hedderwick SA, Kauffman CA. Effect of hand cleansing with antimicrobial soap or alcohol-based gel on microbial colonization of artificial fingernails worn by health care workers. Clin. Infect. Dis. 32, 367-372 (2001).
74. Larson EL, Cimiotti JP, Haas J et al. Gram-negative bacilli associated with catheter-associated and non-catheter-associated bloodstream infections and hand carriage by healthcare workers in neonatal intensive care units. Pediatr. Crit. Care Med. 6, 457-461 (2005).
75. Pittet D. Improving compliance with hand hygiene in hospitals. Infect. Control Hosp. Epidemiol. 21, 381-386 (2000).
76. Darmstadt GL, Dinulos JG. Neonatal skin care. Pediatr. Clin. North Am. 47, 757-782 (2000).
77. Won SP, Chou HC, Hsieh WS et al. Handwashing program for the prevention of nosocomial infections in a neonatal intensive care unit. Infect. Control Hosp. Epidemiol. 25, 742-746 (2004).
78. Moolenaar RL, Crutcher JM, San Joaquin VH et al. A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit: did staff fingernails play a role in disease transmission? Infect. Control Hosp. Epidemiol. 21, 80-85 (2000).
79. Kennedy AM, Elward AM, Fraser VJ. Survey of knowledge, beliefs, and practices of neonatal intensive care unit healthcare workers regarding nosocomial infections, central venous catheter care, and hand hygiene. Infect. Control Hosp. Epidemiol. 25, 747-752 (2004).
80. Cohen B, Saiman L, Cimiotti J, Larson E. Factors associated with hand hygiene practices in two neonatal intensive care units. Pediatr. Infect. Dis. J. 22, 494-498 (2003).
81. Chudleigh J, Fletcher M, Gould D. Infection control in neonatal intensive care units. J. Hosp. Infect. 61, 123-129 (2005).
82. Lam BCC, Lee J, Lau YL. Hand hygiene practices in a neonatal intensive care unit: a multimodal intervention and impact on nosocomial infection. Pediatrics 114, 565-571 (2004).
83. Borer A, Peled N, Golan A, Buchnik L, Hyam E, Gilad J. Impact of weekly personnel hand cultures on incidence of nosocomial bloodstream infections. The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington DC, USA, 16-19 December 2005.
84. Vernon MO, Hayden MK, Trick WE et al. Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci. Arch. Intern. Med. 166, 306-312 (2006).
85. Hudome SM, Fisher MC. Nosocomial infections in the neonatal intensive care unit. Curr. Opin. Infect. Dis. 14, 303-307 (2001).
86. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. A report from the NNIS System. Am. J. Infect. Control 32, 470-485 (2004).
87. Andersen BM, Lindemanny R, Berghz K et al. Spread of methicillin-resistant Staphylococcus aureus in a neonatal intensive unit associated with understaffing, overcrowding and mixing of patients. J. Hosp. Infect. 50, 18-24 (2002).
88. Doit C, Loukil C, Simon AM et al. Outbreak of Burkholderia cepacia bacteremia in a pediatric hospital due to contamination of lipid emulsion stoppers. J. Clin. Microbiol. 42, 2227-2230 (2004).
89. Bouallegue-Godet O, Ben Salem Y, Fabre L et al. Nosocomial outbreak caused by Salmonella enterica serotype livingstone producing CTX-M-27 extended-spectrum β-lactamase in a neonatal unit in Sousse, Tunisia. J. Clin. Microbiol. 43, 1037-1044 (2005).
90. Golan Y, Doron S, Sullivan B, Snydman DR. Transmission of vancomycin-resistant enterococcus in a neonatal intensive care unit. Pediatr. Infect. Dis. J. 24, 566-567 (2005).
91. Huang YC, Su LH, Wu TL et al. Outbreak of Acinetobacter baumannii bacteremia in a neonatal intensive care unit: clinical implications and genotyping analysis. Pediatr. Inject. Dis. J. 21, 1105-1109 (2002).
92. Milisavljevic V, Wu F, Larson F. et al. Molecular epidemiology of Serratia marcescens outbreaks in two neonatal intensive care units. Infect. Control Hosp. Epidemiol. 25, 719-721 (2004).
93. Khoury J, Jones M, Grim A, Dunne WM Jr, Fraser V. Eradication of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit by active surveillance and aggressive infection control measures. Infect. Control Hosp. Epidemiol. 26, 616-621 (2005).
94. Lally RT, Lanz E, Schrock CG. Rapid control of an outbreak of Staphylococcus aureus on a neonatal intensive care department using standard infection control practices and nasal mupirocin. Am. J. Infect. Control 32, 44-47 (2004).
95. Lupetti A, Tavanti A, Davini P et al. Horizontal transmission of Candida parapsilosis candidemia in a neonatal intensive care unit. J. Clin. Microbiol. 40, 2363-2369 (2002).
96. Macrae MB, Shannon KP, Rayner DM, Kaisery AM, Hoffmanz PN, French GL. A simultaneous outbreak on a neonatal unit of two strains of multiply antibiotic resistant Klebsiella pneumoniae controllable only by ward closure. J. Hosp. Infect. 49, 183-192 (2001).
97. Melamed R, Greenberg D, Porat N et al. Successful control of an Acinetobacter baumannii outbreak in a neonatal intensive care unit. J. Hosp. Infect. 53, 31-38 (2003).
98. Melamed R, Greenberg D, Landau D, Khvatskin S, Shany E, Dagan R. Neonatal nosocomial pneumococcal infections acquired by patient-to-patient transmission. Scand. J. Infect. Dis. 34, 385-386 (2002).
99. Regev-Yochay G, Rubinstein E, Barzilai A et al. Methicillin-resistant Staphylococcus aureus in neonatal intensive care unit. Emerg. Infect. Dis. 11, 453-456 (2005).
100. Ross TL, Fuss EP, Harrington SM, Cai M, Perl TM, Merz WG. Methicillin-resistant Staphylococcus caprae in a neonatal intensive care unit. J. Clin. Microbiol. 43, 363-367 (2005).
101. Talon D, Menget P, Thouverez M et al. Emergence of Enterobacter cloacae as a common pathogen in neonatal units: pulsed-field gel electrophoresis analysis. J. Hosp. Infect. 57, 119-125 (2004).
102. Pessoa-Silva CL, Toscano CM, Moreira BM et al. Infection due to extended-spectrum β-lactamase producing Salmonella enterica subsp. enterica serotype infantis in a neonatal unit. J. Pediatr. 141, 381-387 (2002).
103. Pessoa-Silva CL, Moreira BM, Almeida VC et al. Extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit: risk factors for infection and colonization. J. Hosp. Infect. 53, 19-206 (2003).